Veppanu is a first-in-class PROTAC endocrine therapy that induces ER degradation via E3 ligase engagement, extending beyond receptor antagonism used by SERMs and aromatase inhibitors. VERITAC-2 showed ...
The 2026 NFL Draft is just about here, and it is without a doubt the premier event of the offseason. The best teams in the NFL build through the draft, and you can find instant-impact players in each ...
I started my career with CNET all the way back in 2005, when the (original) Motorola Razrs were all the rage. Since then, I've written about everything from consumer electronics to internet culture ...
It doesn’t matter where you’re camping, what the weather is like, what time of year it is, or how long you’ll be out in the woods for. There’s one thing that’s inevitable: It’s going to get dark. And ...
We may receive a commission on purchases made from links. Whether you spend your days laboring on a work site or in a garage, or count yourself among the millions of home improvement DIYers in the ...
We may receive a commission on purchases made from links. If you want to carry an easily concealable high-powered flashlight like those used by agents of the Federal Bureau of Investigation (FBI), ...
A 3D virtual model of the PKMYT1–PROTAC–CRBN ternary complex depicting how Insilico Medicine’s bifunctional proteolysis-targeting chimera (PROTAC) D16-M1P2 (shown in yellow) inhibits ...
The Meta Quest 3S costs $200 less than the Quest 3, but what does it compromise to get there? I've tested both extensively and am here to compare the two VR headsets to help you decide which is the ...
Reducing the time and expense of engineering PROTAC degraders remains a significant challenge in the pharmaceutical industry. A PROTAC is composed of an E3 ligase ligand (E3-L), a protein of interest ...
As social animals, we humans are hard-wired to learn, thrive, and grow through our relationships — our engagement with and observations of others. Early in life, we rely on teachers and role models ...
Pfizer, Arvinas lose interest in commercializing PROTAC inhibitor, leading to layoffs at the biotech
Having already stripped back their development plans for the estrogen receptor (ER) degrader vepdegestrant on the back of mixed data, Pfizer and Arvinas have now decided to wash their hands of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results